Rapid Micro Biosystems (RPID) Stock: Buy, Sell, or Hold?
RPID - Rapid Micro Biosystems, Inc. Class A Common Stock
$1.31
-0.07 (-5.07%)
▼
5d:
-16.56%
30d:
-37.02%
90d:
-34.17%
WAIT
LOW Confidence
Analysis Updated: Sep 4, 2026 12:00 AM ET
Earnings: Aug 07, 2026
0d
Get Alerted When RPID Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: RPID is down 16.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: RPID is down 16.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: RPID is currently trading at $1.31, which is considered oversold relative to its 30-day fair value range of $1.48 to $1.95.
Technical Outlook: Technically, RPID is in a strong downtrend. The price is currently testing key support at $1.29. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.1% recently.
Market Sentiment: RPID scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $6.67 (+408.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RPID is in a strong downtrend. The price is currently testing key support at $1.29. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.1% recently.
Market Sentiment: RPID scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $6.67 (+408.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.48 -
$1.95
Company Quality Score
40/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.1%)
- BULLISH: Trading 408.9% below Wall St target ($6.67)
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.48 -
$1.95
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.29
Resistance Level
$1.72
Current Trend
Strong Downtrend
Technical data as of
Sep 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.80
Wall Street Target
$6.67
(+408.9%)
Revenue Growth (YoY)
10.9%
Profit Margin
-145.6%
Share & Embed Analysis
Last updated: September 07, 2026 4:29 AM ET
Data refreshes hourly during market hours. Next update: 5:29 AM
Data refreshes hourly during market hours. Next update: 5:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RPID showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 43 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 50 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 49 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 43 HOLD |
